211 related articles for article (PubMed ID: 17926333)
1. Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia.
Hinds PS; Hockenberry MJ; Gattuso JS; Srivastava DK; Tong X; Jones H; West N; McCarthy KS; Sadeh A; Ash M; Fernandez C; Pui CH
Cancer; 2007 Nov; 110(10):2321-30. PubMed ID: 17926333
[TBL] [Abstract][Full Text] [Related]
2. Sleep habits and fatigue of children receiving maintenance chemotherapy for ALL and their parents.
Zupanec S; Jones H; Stremler R
J Pediatr Oncol Nurs; 2010; 27(4):217-28. PubMed ID: 20562390
[TBL] [Abstract][Full Text] [Related]
3. A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pediatric Oncology Group study (now The Children's Oncology Group).
Bell BA; Brockway GN; Shuster JJ; Erdmann G; Sterikoff S; Bostrom B; Camitta BM;
Pediatr Blood Cancer; 2004 Aug; 43(2):105-9. PubMed ID: 15236274
[TBL] [Abstract][Full Text] [Related]
4. Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience.
Rubnitz JE; Lensing S; Zhou Y; Sandlund JT; Razzouk BI; Ribeiro RC; Pui CH
Cancer; 2004 Oct; 101(7):1677-84. PubMed ID: 15378506
[TBL] [Abstract][Full Text] [Related]
5. Pain, sleep disturbance, and fatigue in children with leukemia and their parents: a pilot study.
Gedaly-Duff V; Lee KA; Nail L; Nicholson HS; Johnson KP
Oncol Nurs Forum; 2006 May; 33(3):641-6. PubMed ID: 16676020
[TBL] [Abstract][Full Text] [Related]
6. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high?
Te Poele EM; de Bont ES; Marike Boezen H; Revesz T; Bökkerink JP; Beishuizen A; Nijhuis IJ; Oude Nijhuis CS; Veerman AJ; Kamps WA
Eur J Cancer; 2007 Nov; 43(17):2532-6. PubMed ID: 17702568
[TBL] [Abstract][Full Text] [Related]
8. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
[TBL] [Abstract][Full Text] [Related]
9. Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia.
Yang L; Panetta JC; Cai X; Yang W; Pei D; Cheng C; Kornegay N; Pui CH; Relling MV
J Clin Oncol; 2008 Apr; 26(12):1932-9. PubMed ID: 18421047
[TBL] [Abstract][Full Text] [Related]
10. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
Mitchell CD; Richards SM; Kinsey SE; Lilleyman J; Vora A; Eden TO;
Br J Haematol; 2005 Jun; 129(6):734-45. PubMed ID: 15952999
[TBL] [Abstract][Full Text] [Related]
11. Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemia.
Petersen KB; Müller J; Rasmussen M; Schmiegelow K
Med Pediatr Oncol; 2003 Aug; 41(2):110-4. PubMed ID: 12825213
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapse.
Hijiya N; Stewart CF; Zhou Y; Campana D; Coustan-Smith E; Rivera GK; Relling MV; Pui CH; Gajjar A
Cancer; 2008 May; 112(9):1983-91. PubMed ID: 18318429
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL.
Vallance K; Liu W; Mandrell BN; Panetta JC; Gattuso JS; Hockenberry M; Zupanec S; Yang L; Yang J; Hinds PS
Eur J Cancer; 2010 Jul; 46(10):1848-55. PubMed ID: 20400291
[TBL] [Abstract][Full Text] [Related]
14. Time course of recovery of adrenal function in children treated for leukemia.
Felner EI; Thompson MT; Ratliff AF; White PC; Dickson BA
J Pediatr; 2000 Jul; 137(1):21-4. PubMed ID: 10891816
[TBL] [Abstract][Full Text] [Related]
15. The impact of maintenance therapy on sleep-wake rhythms and cancer-related fatigue in pediatric acute lymphoblastic leukemia.
Steur LMH; Kaspers GJL; van Someren EJW; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Grootenhuis MA; van Litsenburg RRL
Support Care Cancer; 2020 Dec; 28(12):5983-5993. PubMed ID: 32285260
[TBL] [Abstract][Full Text] [Related]
16. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
Niinimäki RA; Harila-Saari AH; Jartti AE; Seuri RM; Riikonen PV; Pääkkö EL; Möttönen MI; Lanning M
J Clin Oncol; 2007 Apr; 25(12):1498-504. PubMed ID: 17442991
[TBL] [Abstract][Full Text] [Related]
17. Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer.
Hinds PS; Hockenberry M; Rai SN; Zhang L; Razzouk BI; McCarthy K; Cremer L; Rodriguez-Galindo C
Oncol Nurs Forum; 2007 Mar; 34(2):393-402. PubMed ID: 17573303
[TBL] [Abstract][Full Text] [Related]
18. The effects of dexamethasone on sleep in young children with acute lymphoblastic leukemia.
Rosen G; Harris AK; Liu M; Dreyfus J; Krueger J; Messinger YH
Sleep Med; 2015 Apr; 16(4):503-9. PubMed ID: 25799940
[TBL] [Abstract][Full Text] [Related]
19. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
20. Infectious toxicity of dexamethasone during all remission-induction chemotherapy: report of two cases and literature review.
Mantadakis E; Danilatou V; Stiakaki E; Kalmanti M
Pediatr Hematol Oncol; 2004; 21(1):27-35. PubMed ID: 14660304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
